Ghost Tree Capital Has Lifted Its Neurocrine Biosciences (NBIX) Position by $4.58 Million; Intel (INTC) Holding Held by Wilsey Asset Management Inc

January 15, 2018 - By Nellie Frank

Wilsey Asset Management Inc increased its stake in Intel Corp (INTC) by 13.26% based on its latest 2017Q3 regulatory filing with the SEC. Wilsey Asset Management Inc bought 29,010 shares as the company’s stock declined 2.96% while stock markets rallied. The institutional investor held 247,864 shares of the semiconductors company at the end of 2017Q3, valued at $9.61 million, up from 218,854 at the end of the previous reported quarter. Wilsey Asset Management Inc who had been investing in Intel Corp for a number of months, seems to be bullish on the $202.36 billion market cap company. The stock decreased 0.39% or $0.17 during the last trading session, reaching $43.24. About 29.97M shares traded. Intel Corporation (NASDAQ:INTC) has risen 19.47% since January 15, 2017 and is uptrending. It has outperformed by 2.77% the S&P500.

Ken Greenberg increased its stake in Neurocrine Biosciences Inc (NBIX) by 50% based on its latest 2017Q3 regulatory filing with the SEC. Ghost Tree Capital Llc bought 75,000 shares as the company’s stock rose 19.84% with the market. The hedge fund run by Ken Greenberg held 225,000 shares of the health care company at the end of 2017Q3, valued at $13.79M, up from 150,000 at the end of the previous reported quarter. Ghost Tree Capital Llc who had been investing in Neurocrine Biosciences Inc for a number of months, seems to be bullish on the $7.20 billion market cap company. The stock increased 3.00% or $2.37 during the last trading session, reaching $81.37. About 895,546 shares traded. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has risen 12.51% since January 15, 2017 and is uptrending. It has underperformed by 4.19% the S&P500.

Since August 4, 2017, it had 0 insider buys, and 11 selling transactions for $10.34 million activity. The insider Lloyd-Smith Malcolm sold 18,084 shares worth $1.40 million. Bozigian Haig P. also sold $1.58 million worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) shares. Grigoriadis Dimitri E. sold 15,354 shares worth $844,470. OBrien Christopher Flint also sold $422,702 worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) shares. Another trade for 4,607 shares valued at $276,420 was made by Gano Kyle on Wednesday, September 6.

Among 12 analysts covering Neurocrine Biosci (NASDAQ:NBIX), 12 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Neurocrine Biosci had 40 analyst reports since August 18, 2015 according to SRatingsIntel. Deutsche Bank initiated Neurocrine Biosciences, Inc. (NASDAQ:NBIX) rating on Thursday, November 3. Deutsche Bank has “Buy” rating and $65 target. The company was initiated on Tuesday, October 18 by Needham. The firm earned “Buy” rating on Tuesday, August 18 by Jefferies. Piper Jaffray maintained the shares of NBIX in report on Wednesday, October 25 with “Buy” rating. Piper Jaffray maintained Neurocrine Biosciences, Inc. (NASDAQ:NBIX) on Monday, January 8 with “Buy” rating. The rating was maintained by H.C. Wainwright on Friday, August 4 with “Buy”. The stock of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has “Buy” rating given on Monday, September 25 by Cowen & Co. The firm has “Buy” rating by H.C. Wainwright given on Wednesday, June 29. H.C. Wainwright maintained Neurocrine Biosciences, Inc. (NASDAQ:NBIX) rating on Tuesday, July 11. H.C. Wainwright has “Buy” rating and $13000 target. Barclays Capital maintained the shares of NBIX in report on Thursday, November 2 with “Overweight” rating.

Ghost Tree Capital Llc, which manages about $470.91M US Long portfolio, decreased its stake in Bristol Myers Squibb Co (NYSE:BMY) by 225,000 shares to 75,000 shares, valued at $4.78M in 2017Q3, according to the filing. It also reduced its holding in Nevro Corp by 50,000 shares in the quarter, leaving it with 115,000 shares, and cut its stake in Gw Pharmaceuticals Plc (NASDAQ:GWPH).

Investors sentiment increased to 1.66 in 2017 Q3. Its up 0.41, from 1.25 in 2017Q2. It is positive, as 22 investors sold NBIX shares while 45 reduced holdings. 32 funds opened positions while 79 raised stakes. 92.69 million shares or 0.83% more from 91.92 million shares in 2017Q2 were reported. Daiwa Sb Invests Ltd reported 0.02% of its portfolio in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Ny State Common Retirement Fund holds 0.02% or 260,296 shares. Quantitative Management Llc owns 67,500 shares. Envestnet Asset Mgmt holds 0% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) or 377 shares. State Of Wisconsin Board stated it has 17,784 shares. X Management Communication Lc invested 0% of its portfolio in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Jane Street holds 0% of its portfolio in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) for 16,499 shares. Metropolitan Life New York holds 6,588 shares. Redmile Group Incorporated Llc reported 0.02% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Dafna Capital Mgmt Limited Liability Co stated it has 2.07% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). 4.79M were accumulated by Perceptive Advsr Ltd. Schroder Mgmt Grp Inc reported 37,105 shares. Grandfield Dodd Limited Company owns 7,610 shares. The Massachusetts-based Fmr Limited has invested 0.1% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). California Pub Employees Retirement Sys reported 181,900 shares or 0.02% of all its holdings.

Investors sentiment is 1.03 in 2017 Q3. Its the same as in 2017Q2. It is the same, as 52 investors sold INTC shares while 663 reduced holdings. only 127 funds opened positions while 608 raised stakes. 3.05 billion shares or 0.19% more from 3.05 billion shares in 2017Q2 were reported. Patten & Patten Tn accumulated 1.5% or 374,070 shares. Nationwide Fund Advisors has invested 0.29% in Intel Corporation (NASDAQ:INTC). Bnp Paribas Asset Mgmt Hldgs Sa has 0.12% invested in Intel Corporation (NASDAQ:INTC) for 384,664 shares. Marietta Inv Prtn Ltd Liability stated it has 0.13% of its portfolio in Intel Corporation (NASDAQ:INTC). Sfe Invest Counsel stated it has 1.21% of its portfolio in Intel Corporation (NASDAQ:INTC). Telemus Limited Liability Company stated it has 20,371 shares. Forbes J M And Co Ltd Liability Partnership owns 25,619 shares. At Comml Bank accumulated 58,725 shares. 5,997 were reported by Summit Asset Management. Cleararc owns 0.69% invested in Intel Corporation (NASDAQ:INTC) for 120,760 shares. 14,901 were accumulated by Bankshares Hapoalim Bm. Evanston Dba Evanston accumulated 217,750 shares. Royal Natl Bank Of Scotland Public Ltd Co owns 606,769 shares. Stewart & Patten Lc holds 3.81% or 548,865 shares. -based Farr Miller & Washington Limited Liability Dc has invested 0.28% in Intel Corporation (NASDAQ:INTC).

Among 54 analysts covering Intel Corporation (NASDAQ:INTC), 34 have Buy rating, 5 Sell and 15 Hold. Therefore 63% are positive. Intel Corporation had 207 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Hold” rating by Canaccord Genuity given on Friday, November 17. Canaccord Genuity maintained the shares of INTC in report on Friday, October 27 with “Hold” rating. Bernstein upgraded Intel Corporation (NASDAQ:INTC) on Friday, July 8 to “Market Perform” rating. Topeka Capital Markets maintained Intel Corporation (NASDAQ:INTC) on Monday, January 18 with “Buy” rating. The stock has “Hold” rating by RBC Capital Markets on Wednesday, July 12. On Friday, October 27 the stock rating was maintained by Northland Capital with “Hold”. Mizuho maintained the shares of INTC in report on Thursday, October 26 with “Buy” rating. The stock has “Buy” rating by Jefferies on Wednesday, October 14. Citigroup maintained the shares of INTC in report on Friday, August 21 with “Neutral” rating. The stock has “Neutral” rating by Goldman Sachs on Wednesday, February 3.

Since July 31, 2017, it had 0 insider buys, and 10 insider sales for $31.43 million activity. Shares for $67,048 were sold by Bryant Diane M. $51,834 worth of Intel Corporation (NASDAQ:INTC) was sold by RENDUCHINTALA VENKATA S M. BRYANT ANDY D also sold $3.99M worth of Intel Corporation (NASDAQ:INTC) shares. Shares for $2.40M were sold by Krzanich Brian M. 30,000 shares were sold by YOFFIE DAVID B, worth $1.35M on Monday, October 30.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.